The trading price of Vanda Pharmaceuticals Inc (NASDAQ:VNDA) closed higher on Friday, April 19, closing at $5.11, 2.82% higher than its previous close.
The company’s P/E ratio in the trailing 12-month period was 116.93. In examining the 52-week price action we see that the stock hit a 52-week high of $7.00 and a 52-week low of $3.30. Over the past month, the stock has gained 34.47% in value.
Vanda Pharmaceuticals Inc, whose market valuation is $294.03 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Vanda Pharmaceuticals Inc No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest VNDA has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 50% Buy.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 3.24, which symbolizes a positive outlook. A quick review shows that VNDA’s price is currently 18.53% off the SMA20 and 21.49% off the SMA50. The RSI metric on the 14-day chart is currently showing 63.71, and weekly volatility stands at 6.90%. When measured over the past 30 days, the indicator reaches 7.13%. Vanda Pharmaceuticals Inc (NASDAQ:VNDA)’s beta value is currently sitting at 0.69, while the Average True Range indicator is currently displaying 0.37.
To see how Vanda Pharmaceuticals Inc stock has been performing in comparison to its peers in the industry, here are the numbers: VNDA stock’s performance was 2.82% in the latest trading, and -18.63% in the past year. Vanda Pharmaceuticals Inc has a P/E ratio of 116.93.
An evaluation of the daily trading volume of Vanda Pharmaceuticals Inc (NASDAQ:VNDA) indicates that the 3-month average is 2.27 million.
Currently, records show that 57.53 million of the company’s shares remain outstanding. The insiders hold 5.26% of outstanding shares, whereas institutions hold 88.39%. However, since the stock’s price has seen 21.09% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
